Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico

Author： Whittington D. Matsui-Santana O. Freiberger J.J. Van Houtven G. Pattanayak S.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.19, 2002-06, pp. : 2585-2591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic AIDS vaccine by targeting HIV receptor

By Wang C.Y. Shen M. Tam G. Fang X.D. Ye J. Shen F. Walfield A.M. Wang J.J.G. Li M.L. Li X.M. Salas M. Shearer M.H. Kennedy R.C. Hanson C.V.

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 89-97

Elsevier

Access to resources Recommend Favorite

Diffusion of Innovations and HIV/AIDS

By BERTRAND JANE T.

Journal of Health Communication, Vol. 9, Iss. 1, 2004-06 ,pp. : 113-121

Taylor & Francis Ltd

Access to resources Recommend Favorite

HIV/AIDS: The Prioritization of Prevention

By Ratzan Scott

Journal of Health Communication, Vol. 9, Iss. 5, 2004-09 ,pp. : 385-386

Taylor & Francis Ltd

Access to resources Recommend Favorite

Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine

By Hilleman M.R.

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1733-1740

Elsevier

Access to resources Recommend Favorite

The Role of the Pharmacist in the Management of HIV/AIDS

By Zappa A.J.

Disease Management & Health Outcomes, Vol. 6, Iss. 1, 1999-07 ,pp. : 19-28

Adis International

Access to resources Recommend Favorite